STOCK TITAN
  1. Home
  2. TALS

TALS (TALS) Stock Price, News & Analysis

TALS NASDAQ

Company Description

TALS (NASDAQ: TALS) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for TALS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
-2.84%

Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio

acquisition
0.00%

Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio

dividends acquisition
+22.73%

Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement

acquisition
+4.12%

Talaris Therapeutics Announces Leadership Transition

management
+24.05%

Talaris Therapeutics Announces Plans to Explore Strategic Alternatives and Implements Restructuring Plan

-2.11%

Talaris Therapeutics to Participate at the 5th Annual Evercore ISI HealthCONx Conference

conferences

TALS has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, dividends, management, conferences, earnings. View all TALS news →

SEC Filings

View All

No SEC filings available for TALS.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

TALS Company Profile & Sector Positioning

TALS (TALS) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.